vs
Side-by-side financial comparison of ASIA PACIFIC WIRE & CABLE CORP LTD (APWC) and AVANOS MEDICAL, INC. (AVNS). Click either name above to swap in a different company.
ASIA PACIFIC WIRE & CABLE CORP LTD is the larger business by last-quarter revenue ($225.3M vs $180.9M, roughly 1.2× AVANOS MEDICAL, INC.).
Disney Networks Group Asia Pacific was a Hong Kong–based commercial broadcasting company operating multiple specialty television channels. The company was founded in 1991 by Hong Kong - Canadian businessman Richard Li.
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
APWC vs AVNS — Head-to-Head
Income Statement — Q2 FY2022 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $225.3M | $180.9M |
| Net Profit | — | $-1.3M |
| Gross Margin | 7.9% | 47.5% |
| Operating Margin | 2.2% | 1.4% |
| Net Margin | — | -0.7% |
| Revenue YoY | — | 0.7% |
| Net Profit YoY | — | 99.7% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $180.9M | ||
| Q3 25 | — | $177.8M | ||
| Q2 25 | — | $175.0M | ||
| Q1 25 | — | $167.5M | ||
| Q4 24 | — | $179.6M | ||
| Q3 24 | — | $170.4M | ||
| Q2 24 | — | $171.7M | ||
| Q1 24 | — | $166.1M |
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-1.4M | ||
| Q2 25 | — | $-76.8M | ||
| Q1 25 | — | $6.6M | ||
| Q4 24 | — | $-397.3M | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-900.0K |
| Q4 25 | — | 47.5% | ||
| Q3 25 | — | 48.4% | ||
| Q2 25 | — | 52.6% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 54.6% | ||
| Q3 24 | — | 54.5% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 57.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | -42.6% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | -233.0% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | — | -0.7% | ||
| Q3 25 | — | -0.8% | ||
| Q2 25 | — | -43.9% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -221.2% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | -0.5% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-1.66 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $-8.64 | ||
| Q3 24 | — | $0.09 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | — | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $89.8M |
| Total DebtLower is stronger | — | $90.3M |
| Stockholders' EquityBook value | — | $778.2M |
| Total Assets | — | $1.1B |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $89.8M | ||
| Q3 25 | — | $70.5M | ||
| Q2 25 | — | $90.3M | ||
| Q1 25 | — | $97.0M | ||
| Q4 24 | — | $107.7M | ||
| Q3 24 | — | $89.0M | ||
| Q2 24 | — | $92.2M | ||
| Q1 24 | — | $75.8M |
| Q4 25 | — | $90.3M | ||
| Q3 25 | — | $93.4M | ||
| Q2 25 | — | $95.7M | ||
| Q1 25 | — | $98.0M | ||
| Q4 24 | — | $125.3M | ||
| Q3 24 | — | $152.6M | ||
| Q2 24 | — | $164.9M | ||
| Q1 24 | — | $167.2M |
| Q4 25 | — | $778.2M | ||
| Q3 25 | — | $778.0M | ||
| Q2 25 | — | $776.3M | ||
| Q1 25 | — | $839.4M | ||
| Q4 24 | — | $828.5M | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.13× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $28.2M |
| Free Cash FlowOCF − Capex | — | $21.3M |
| FCF MarginFCF / Revenue | — | 11.8% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.2M | ||
| Q3 25 | — | $14.0M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $25.7M | ||
| Q4 24 | — | $57.9M | ||
| Q3 24 | — | $23.0M | ||
| Q2 24 | — | $27.8M | ||
| Q1 24 | — | $-8.0M |
| Q4 25 | — | $21.3M | ||
| Q3 25 | — | $7.0M | ||
| Q2 25 | — | $-4.2M | ||
| Q1 25 | — | $19.0M | ||
| Q4 24 | — | $53.1M | ||
| Q3 24 | — | $20.0M | ||
| Q2 24 | — | $21.9M | ||
| Q1 24 | — | $-12.1M |
| Q4 25 | — | 11.8% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | -2.4% | ||
| Q1 25 | — | 11.3% | ||
| Q4 24 | — | 29.6% | ||
| Q3 24 | — | 11.7% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | -7.3% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 6.3% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.35× | ||
| Q2 24 | — | 15.44× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APWC
Segment breakdown not available.
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
